a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND）
Recruiting now
Conditions studied: Cancer
In brief
This study is a multi-center, case-control study aiming at developing and blinded testing machine learning-based multiple cancers early detection model by prospectively collecting blood samples from newly diagnosed cancer patients and individuals without confirmed cancer diagnosis.
Key facts
- Study ID
- NCT06217900
- Run by
- Shanghai Weihe Medical Laboratory Co., Ltd.
- People needed
- 16666
- Starts
- 2023-12-28
- Expected to finish
- 2027-03-31
- Last updated by the study team
- 2024-01-23
Who can join
Age: 40 and older, up to 74. Sex: any. Healthy volunteers: accepted.
Where it is running
- Peking University People's Hospital — Beijing, Beijing Municipality, China (enrolling)
- Peking University Cancer Hospital and Institute — Beijing, Beijing Municipality, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.